BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $68.53 -2.43%
Financial Fact:
Collaborative agreement revenues: 1K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Collaborative agreement revenues: 1K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $1.13, $0.43 better than the analyst estimate of $0.70. Revenue for the quarter came in at $745 million versus the consensus estimate of $741.02 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- Bernstein SocGen Group Upgrades Wayfair (W) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
